A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (Q74117541)
Jump to navigation
Jump to search
scientific article published on 01 May 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy |
scientific article published on 01 May 2002 |
Statements
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (English)
Clemens A Schmitt
Jordan S Fridman
Meng Yang
Eugene Baranov
Robert M Hoffman